drugset / Trial / NCT00548496

A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius

NCT00548496 ↗

Phase 2 Terminated 86 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study designed to test the safety and effectiveness of SB-751689 in the treatment of a distal radius fracture in post-menopausal women and men in comparison to placebo to determine if healing time of the fracture can be decreased.

Timeline

Start
2007-09-20
Primary completion
2008-11-26
Completion
2008-11-26

Outcome

Missed primary endpoint

Stopped: “Lack of efficacy”

paper Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time PMID 21742071 ↗

paper There were no significant differences between treatment groups in time to radiographic fracture healing PMID 21742071 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject SB-751689 Unknown 200 mg Oral
Subject SB-751689 Unknown 400 mg Oral

Indications

No indication recorded.